Samangadi Churna Lehana for Improving Intelligence in Children

Efficacy of Samangadi Churna Lehana in the management of below average intelligence quotient (IQ), borderline IQ, and mild intellectual disability in children: A double-blind randomised placebo-controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102621

Enrollment

Registered

2026-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F70- Mild intellectual disabilities

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 10 to 15 years with an IQ range of 89 to 50, irrespective of gender, religion, socio-economic background, or dietary habits. Children who meet the screening criteria and their parents provide informed consent by signing the agreement for their participation in the clinical trial.

Exclusion criteria

Exclusion criteria: Children with other neurodevelopmental disorders, psychiatric disorders associated with intellectual disability. Children diagnosed with physical neurological diseases, such as autism, Down syndrome, Rett syndrome, Fragile X syndrome, and cerebral palsy. Children with any other chronic systemic illness and congenital disorders.

Design outcomes

Primary

Measure	Time frame
Change in IQ level.Timepoint: 0th Day and 85th Day	—

Secondary

Measure	Time frame
Changes in serum NGF Beta and Vit B12 level Changes in mini mental state examination Improvement in morbidity scoreTimepoint: 0th day and 85th day	—

Countries

India

Contacts

Public ContactProf Dr V K Kori

Institute of Teaching and Research in Ayurveda (INI), Jamnagar, Gujarat

drvkkori@itra.edu.in9409207278

Outcome results